These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34192269)

  • 1. Impact of obesity and SARS-CoV-2 infection: implications for host defence - a living review.
    Richter FC; Alrubayyi A; Teijeira Crespo A; ; Hulin-Curtis S
    Oxf Open Immunol; 2021; 2(1):iqab001. PubMed ID: 34192269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulated Inflammation During Obesity: Driving Disease Severity in Influenza Virus and SARS-CoV-2 Infections.
    Hulme KD; Noye EC; Short KR; Labzin LI
    Front Immunol; 2021; 12():770066. PubMed ID: 34777390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Influenza Virus to Novel Corona Virus (SARS-CoV-2)-The Contribution of Obesity.
    Bhattacharya I; Ghayor C; Pérez Dominguez A; Weber FE
    Front Endocrinol (Lausanne); 2020; 11():556962. PubMed ID: 33123087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets.
    Huang Y; Skarlupka AL; Jang H; Blas-Machado U; Holladay N; Hogan RJ; Ross TM
    J Virol; 2022 Mar; 96(5):e0179121. PubMed ID: 34936487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes.
    Crisan-Dabija R; Grigorescu C; Pavel CA; Artene B; Popa IV; Cernomaz A; Burlacu A
    Can Respir J; 2020; 2020():1401053. PubMed ID: 32934758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection.
    Totura AL; Whitmore A; Agnihothram S; Schäfer A; Katze MG; Heise MT; Baric RS
    mBio; 2015 May; 6(3):e00638-15. PubMed ID: 26015500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity.
    Menachery VD; Yount BL; Josset L; Gralinski LE; Scobey T; Agnihothram S; Katze MG; Baric RS
    J Virol; 2014 Apr; 88(8):4251-64. PubMed ID: 24478444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements.
    Marston JL; Greenig M; Singh M; Bendall ML; Duarte RRR; Feschotte C; Iñiguez LP; Nixon DF
    JCI Insight; 2021 Dec; 6(24):. PubMed ID: 34731091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
    Mirzaei R; Mahdavi F; Badrzadeh F; Hosseini-Fard SR; Heidary M; Jeda AS; Mohammadi T; Roshani M; Yousefimashouf R; Keyvani H; Darvishmotevalli M; Sani MZ; Karampoor S
    Int Immunopharmacol; 2021 Jan; 90():107204. PubMed ID: 33221169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection.
    Oishi K; Horiuchi S; Minkoff JM; tenOever BR
    J Virol; 2022 Aug; 96(15):e0076522. PubMed ID: 35862681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection.
    Chen P; Wu M; He Y; Jiang B; He ML
    Signal Transduct Target Ther; 2023 Jun; 8(1):237. PubMed ID: 37286535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus.
    Ekanger CT; Zhou F; Bohan D; Lotsberg ML; Ramnefjell M; Hoareau L; Røsland GV; Lu N; Aanerud M; Gärtner F; Salminen PR; Bentsen M; Halvorsen T; Ræder H; Akslen LA; Langeland N; Cox R; Maury W; Stuhr LEB; Lorens JB; Engelsen AST
    Front Cell Infect Microbiol; 2022; 12():841447. PubMed ID: 35360113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella.
    Méry G; Epaulard O; Borel AL; Toussaint B; Le Gouellec A
    Front Immunol; 2020; 11():1714. PubMed ID: 32793244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory Syncytial Virus Protects Bystander Cells against Influenza A Virus Infection by Triggering Secretion of Type I and Type III Interferons.
    Czerkies M; Kochańczyk M; Korwek Z; Prus W; Lipniacki T
    J Virol; 2022 Nov; 96(22):e0134122. PubMed ID: 36326278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global dynamics of IAV/SARS-CoV-2 coinfection model with eclipse phase and antibody immunity.
    Elaiw AM; Alsulami RS; Hobiny AD
    Math Biosci Eng; 2023 Jan; 20(2):3873-3917. PubMed ID: 36899609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune evasion of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); molecular approaches.
    Ahmadi S; Bazargan M; Elahi R; Esmaeilzadeh A
    Mol Immunol; 2023 Apr; 156():10-19. PubMed ID: 36857806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 infection alters mitochondrial and cytoskeletal function in human respiratory epithelial cells mediated by expression of spike protein.
    Yeung-Luk BH; Narayanan GA; Ghosh B; Wally A; Lee E; Mokaya M; Wankhade E; Zhang R; Lee B; Park B; Resnick J; Jedlicka A; Dziedzic A; Ramanathan M; Biswal S; Pekosz A; Sidhaye VK
    mBio; 2023 Aug; 14(4):e0082023. PubMed ID: 37504520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza A and Respiratory Syncytial Virus Trigger a Cellular Response That Blocks Severe Acute Respiratory Syndrome Virus 2 Infection in the Respiratory Tract.
    Dee K; Schultz V; Haney J; Bissett LA; Magill C; Murcia PR
    J Infect Dis; 2023 Jun; 227(12):1396-1406. PubMed ID: 36550077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
    Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
    J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.